Over recent years, nanotoxicology and the potential effects on human body have grown in significance, the potential influences of nanosized materials on the central nervous system have received more attention. The aim of this study was to determine whether zinc oxide (ZnO) nanoparticles (NPs) exposure cause alterations in emotional behavior and trace elements homeostasis in rat brain. Rats were treated by intraperitoneal injection of ZnO NPs (20–30 nm) at a dose of 25 mg/kg body weight. Sub-acute ZnO NPs treatment induced no significant increase in the zinc content in the homogenate brain. Statistically significant decreases in iron and calcium concentrations were found in rat brain tissue compared to control. However, sodium and potassium contents remained unchanged. Also, there were no significant changes in the body weight and the coefficient of brain. In the present study, the anxiety-related behavior was evaluated using the plus-maze test. ZnO NPs treatment modulates slightly the exploratory behaviors of rats. However, no significant differences were observed in the anxious index between ZnO NP-treated rats and the control group (p > 0.05). Interestingly, our results demonstrated minimal effects of ZnO NPs on emotional behavior of animals, but there was a possible alteration in trace elements homeostasis in rat brain.
BeardJEriksonKMJonesBC (2003) Neonatal iron deficiency results in irreversible changes in dopamine function in rats. Journal of Nutrition133: 1174–1179.
2.
BeyersmannDHaaseH (2001) Functions of zinc in signaling, proliferation and differentiation of mammalian cells. Biometals14: 331–341.
3.
CampbellAOldhamMBecariaABondySCMeacherDSioutasC. (2005) Particulate matter in polluted air may increase biomarkers of inflammation in mouse brain. Neurotoxicology26: 133–140.
4.
ConguiLChiccaMPilastroATurchettoMTallandiniL (2000) Effects of chronic dietary cadmium on hepatic glutathione levels and glutathione peroxidase activity in starlings. Archives of Environmental Contamination and Toxicology38: 357–361.
5.
CristinaBIvanIPachecoBKevinR (2007) Nanomaterials and nanoparticles: sources and toxicity. Biointerphases2(4): 17–172.
6.
DadongHYutaoTTaoZGuogangEZhuoY (2011) Nano-zinc oxide damages spatial cognition capability via over-enhanced long-term potentiation in hippocampus of Wistar rats. International Journal of Nanomedicine6: 1453–1461.
El MirLAmloukABarthouCAlayaS (2007) Synthesis and luminescence properties of ZnO/Zn2SiO4/SiO2 composite based on nanosized zinc oxide confined silica aerogels. Journal of Physica B388: 412–417.
9.
El MirLAmloukABarthouCAlayaS (2008) Luminescence of composites based on oxide aerogels incorporated in silica glass host matrix. Journal Materials Science and Engineering: C 28: 771–776.
10.
FayedA-H (2010) Brain trace element concentration of rats treated with the plant alkaloid, vincamine. Biological Trace ElementResearch136(3): 314–319.
11.
FryeCAPetraliaSMRhodesME (2000) Estrous cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3alpha, 5alpha-THP. Pharmacology Biochemistry and Behavior67: 587–596.
12.
GabrielAS (2008) Nanotechnology approaches to crossing the blood–brain barrier and drug delivery to the CNS. BMC Neuroscience9(Suppl 3): S4.
13.
Jin-HuaYYuCHe-XiaZLi-JunSChun-YeLJie-QuanL. (2010) Determination, characterization and cytotoxicity on HELF cells of ZnO nanoparticles. Colloids and Surfaces B: Biointerfaces76: 145–150.
14.
KatarzynaKRebeccaJS (2004) New evidence of iron and zinc interplay at the enterocyte and neural tissues. American Society for Nutritional Sciences134(6): 1295–1298.
15.
LiuGMenaPHarrisPRLRolstonRKPerryGSmithMA (2006) Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance. Neuroscience Letters406: 189–193.
16.
MaaroufiKAmmariMJeljeliMRoyVSaklyMAbdelmelekH (2009) Impairment of emotional behavior and spatial learning in adult Wistar rats by ferrous sulfate. Physiology and Behavior96: 343–349.
17.
MadsenEGitlinJD (2007) Copper and iron disorders of the brain. Annual Review of Neuroscience30: 317–337.
18.
MathieASuttonGLClarkeCEVealeEL (2006) Zinc and copper: pharmacological probes and endogenous modulators of neuronal excitability. Pharmacology and Therapeutics11: 567–583.
19.
OsmondMJMcCallMJ (2010) Zinc oxide nanoparticles in modern sunscreens: an analysis of potential exposure and hazard. Nanotoxicology4(1): 15–41.
20.
PellowSChopinPFileSEBrileyM (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods14: 149–167.
21.
PellowSFileSE (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacology Biochemistry and Behavior24: 525–529.
22.
RasmussenJWMartinezELoukaPWingettDG (2010) Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opinion on Drug Delivery7(9): 1063–1077.
23.
RemillardCV (2004) Channels an essential pathway in programmed cell??Yuan JX-J Activation of K death. American Journal of Physiology-Lung Cellular and Molecular Physiology286: 49–67.
24.
RenpingHXiaolanGYanmeiDNaLYiCYalingC. (2010) Neurotoxicological effects and the impairment of spatial recognition memory in mice caused by exposure to TiO2 nanoparticles. Biomaterials31: 8043–8050.
25.
RodgersRJDalviA (1997) Anxiety, defence and the elevated plus-maze. Neuroscience & Biobehavioral Reviews21: 801–810.
26.
RoyVChapillonP (2004) Further evidences that risk assessment and object exploration behaviours are useful to evaluate emotional reactivity in rodents. Behavioural Brain Research154: 439–448.
27.
SandsteadHHFredericksonCJPenlandJG (2000) History of zinc as related to brain function. Journal of Nutrition130: 4965–5025.
28.
SharmaHSHussainSSchlagerJAliS FSharmaA (2010) Influence of nanoparticles on blood–brain barrier permeability and brain edema formation in rats. Acta Neurochirurgica106: 359–364.
29.
SongWWuCYinHLiuXSaPHuJ (2008) Preparation of PbS nanoparticles by phase-transfer method and application to pb-selective electrode based on PVC membrane. Analytical Letters41(15): 2844–2859.
30.
StaggersNMcCaskyTBrazeltonNKennedyR (2008) Nanotechnology: the coming revolution and its implications for consumers, clinicians, and informatics. Nursing Outlook56(5): 268–274.
31.
TakedaA (2001) Zinc homeostasis and functions of zinc in the brain. Biometals14(3–4): 343–351.
32.
TangJXiongLWangSWangJLiuLLiJ. (2009) Distribution, translocation and accumulation of silver nanoparticles in rats. Journal for Nanoscience and Nanotechnology9: 4924–4932.
33.
TreitDMenardJRoyanC (1993) Anxiogenic stimuli in the elevated plus-maze. Pharmacology Biochemistry and Behavior44: 463–469.
34.
Thilsing-HansenTJørgensenRJ (2001) Serum calcium response following oral zinc oxide administrations in dairy cows. Acta Veterinaria Scandinavica42: 271–278.
35.
UngerELPaulTMurray-KolbLEFeltBJonesBCBeardJL (2007) Early iron deficiency alters sensorimotor development and brain monoamines in rats. Journal of Nutrition137: 118–124.
36.
WangHJGrowcockACTangTHO’HaraJHuangYWAronstamRS (2010) Zinc oxide nanoparticle disruption of store-operated calcium entry in a muscarinic receptor signaling pathway. Toxicology In Vitro24(7): 1953–1961.
37.
YonglingXWangYZhangTRenGYangZ (2012) Effects of nanoparticle zinc oxide on spatial cognition and synaptic plasticity in mice with depressive-like behaviors. Journal of Biomedical Science19: 14.
38.
YoudimMBBen-ShacharDYehudaS (1989) Putative biological mechanisms of the effect of iron deficiency on brain biochemistry and behavior. The American Journal of Clinical Nutrition50: 607–615.
39.
ZhaoJXuLZhangTRenGYangZ (2009) Influences of nanoparticle zinc oxide on acutely isolated rat hippocampal CA3 pyramidal neurons. Neurotoxicology30(2): 220–230.
